JLM-BioCity Innovations

JLM-BioCity Pharma Diabetes "Oral Insulin"

Oramed Provides Clinical Update with Meaningful Data Expected by Year-End

October 3, 2019

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) , a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today provided a clinical update regarding four ongoing

New York Arcview Investor Forum Honors “Father of Cannabis Research” Raphael Mechoulam with $10K Award

October 3, 2019

The Arcview Group will honor “The Father of Cannabis Research” with a Lifetime Achievement Award and a $10,000 research grant in their first annual cannabis

Oramed Provides Clinical Update with Meaningful Data Expected by Year-End

July 5, 2019

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) , a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today provided a clinical update regarding four ongoing

RAFA and Panaxia’s Medical Cannabis Oil examined by Israeli Ministry of Health

June 7, 2019

For the first time in Israeli history, The Israeli Ministry of Health will discuss including medical cannabis in the Health and Drug Baskets. Axiban, Panaxia Pharmaceutical Industries‘ Medical Cannabis

RenalSense Receives new Innovation Authority $828,000 R&D Grant

June 7, 2019

The Israeli Ministry of Economy and Industry and the Israel Innovation Authority have funded over NIS 25 million ($6.9 million) in grants to innovative medical technology

RenalSense Receives new Innovation Authority $828,000 R&D Grant

June 7, 2019

The Israeli Ministry of Economy and Industry and the Israel Innovation Authority have funded over NIS 25 million ($6.9 million) in grants to innovative medical technology

RenalSense Receives new Innovation Authority $828,000 R&D Grant

June 7, 2019

The Israeli Ministry of Economy and Industry and the Israel Innovation Authority have funded over NIS 25 million ($6.9 million) in grants to innovative medical technology

RespiDx’s spin-off, OmnySense, commercializes its comprehensive remote checkups Multimometer

June 7, 2019

RespiDx has created a new spin-off, OmnySense, to commercialize its Multimometer for comprehensive remote checkups. RespiDx has developed a technology platform for a comprehensive physiological check-up,

FameWave Acquisition Marks Kitov’s Transition Into Oncology

June 7, 2019

Kitov Pharma recently contracted an arrangement to acquire FameWave Ltd. for a share exchange transaction. FameWave shareholders will receive $10M worth of newly issued KTOV ADSs (U.S. Listing)

Because every biotech and medtech professional knows that Jerusalem BioCity consistently delivers world-class programming, the best professionals always show up and the networking before and after the events is worth its time in gold.

- Moshe Lebowitz, CEO, Healables Digital Health | Healables: Wearables that Heal

The JLM Biocity networking events on Zoom keeps getting better. For OmnySense they have provided an excellent forum in which to present our company, and the break-out sessions facilitate direct discussion with a broad range of potential partners and investors.

- Ian Solomon CTO, OmnySense Ltd.

JLM-BioCity's events are well organized with a professional approach. You can feel a "homey" atmosphere around the people of a well-maintained bio-community in Jerusalem. Team members always make sure the guests feel welcome and connected to the right people for possible collaborations. There are clearly visible good-will and dedication to lead the members of the bio-community and the city as a whole to success.

- Dror Chevion CEO, Concenter BioPharma

I believe in the idea of JLM-BioCity. It is good that there is an organization that represents the life science companies in Jerusalem and provides an excellent platform for networking through its regular meetings.

- Immanuel Lerner CEO, Pepticom

Excellent event. Good speakers, interesting audience. Well done!

- Gideon Silberman, Director of Business Development, Partner and Co-Founder, Aneeva.com

Thank you all for the great evening, it was a pleasure to see such a good and diverse set of Biomed minded people in Jerusalem!

- Zeev Malyutin, Protein Department Head, Merck KGaA

Such an interesting lecture and great people attending!

- Aurélie Schwarzbach, Clinical Project Manager, Gamida Cell Ltd.

Interesting - I could see it helping people network - a good thing!

- Jonathan Miller, Founder, President, and Designer, U-Step, Neurological Walking Aids

Great atmosphere, great people.

- Yael Ophir, Executive Director, HealthIL

There was an excellent networking atmosphere with impressive Panelists as well as high-quality audience participants. I strongly recommend paying attention to future events.

Aviv Marom, Director, Strategic Partnerships, Samsung Research, Israel

Very informative and eye-opening event. Thank you for the great hospitality.

- Hemda Idel, founder, SLEEP ASAP

one of the best meetups organizations and a very important source of information and connections for startups.

Tal Or, Co-Founder, ATLASense Biomed Ltd.

Excellent organization (from the timing to food), the quality of the audience was superior, we personally got a lot of hot leads.

Alexander Naslednikov, Founder and CEO, Med.me

<< Prev

Next >>

JLM-BioCity was recently written up in THE MARKER (in Hebrew). To see the article, click here.

Oramed Provides Clinical Update with Meaningful Data Expected by Year-End

New York Arcview Investor Forum Honors “Father of Cannabis Research” Raphael Mechoulam with $10K Award

Oramed Provides Clinical Update with Meaningful Data Expected by Year-End

RAFA and Panaxia’s Medical Cannabis Oil examined by Israeli Ministry of Health

RenalSense Receives new Innovation Authority $828,000 R&D Grant

RenalSense Receives new Innovation Authority $828,000 R&D Grant

RenalSense Receives new Innovation Authority $828,000 R&D Grant

RespiDx’s spin-off, OmnySense, commercializes its comprehensive remote checkups Multimometer

FameWave Acquisition Marks Kitov’s Transition Into Oncology

Strategic Partners

Platinum

Gold

Silver

Contact us at

Follow us

Copyright © 2020 JLM-BioCity | All rights reserved